In an event which is so far unique given the ridiculously high minimum market cap requirement of £30m for the Standard List of the LSE, Hydrogen Utopia International (HUI), a waste plastic to hydrogen group, confirmed trading on the main market of the London Stock Exchange, has been approved by the FCA.
The news has already been described by an investor in HUI as “Escape from Alcatraz.” The company said “Following Voltaire: ” Go into the London Stock Exchange – a more respectable place than many a court.” Admission will commence at 08:00 GMT on 21 December 2022, under the symbol “HUI”.
Perhaps a more analogous Escape from Alcatraz is Iconic Labs (ICON). It announced that both the High Court of Justice, Business & Property Court, and Companies House have confirmed and accepted the Joint Administrators’ Final Report. With administration now ceased, the company said its priority now is to continue working with the FCA to get the suspension of the company’s shares lifted as soon as possible.
It would appear that QTZ has cracked it. Quetzal Capital (QTZ) announced that it has published an admission document in connection with its proposed acquisition of Tap Global Limited, the regulated, fully integrated provider of fiat banking and crypto settlement services. In connection Quetzal has obtained commitments from investors to subscribe for £3.1 million of new equity at 4.5p.
Oxford BioDynamics, (OBD), a biotechnology company, announced the initial results from an interim analysis conducted for the REFINE-ALS prospective trial. The results from a subset of data, highlight the blood-based EpiSwitch prognostic stratification of patients with fast progressing Amyotrophic Lateral Sclerosis (ALS). The company said it was delighted with the initial interim results reported about the use of EpiSwitch in the REFINE-ALS trial. Robust clinical biomarkers based on liquid biopsy have been long predicted to change the practice of medicine, and if proven, could become part of medical standards in XXI century.
Redx (REDX), the clinical-stage biotechnology company, announced that the company has entered into a clinical trial collaboration and supply agreement with MSD (Merck & Co., Inc., Rahway, NJ, USA), for the supply of KEYTRUDA® (pembrolizumab), MSD’s anti-PD-1 therapy.
NetScientific (NSCI), an investment and commercialisation group, reported that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB), has announced the completion of enrolment in the first stage of the checkpoint inhibitor refractory group of its VERSATILE-002 Phase 2 study for the potential treatment of recurrent and/or metastatic human papillomavirus (HPV16)-positive head and neck cancer.
Dev Clever (DEV) announced that it intends to submit a request to the good people at the FCA for the cancellation of the listing of the Company’s ordinary shares on the Official List and trading on the LSE. The company said steps have begun to complete a rebranding exercise of the Company and its subsidiaries under the “Veative” banner and the Company’s name will change to Veative Group plc.
Fulham Shore (FUL), the owner and operator of The Real Greek and (delicious and great value) Franco Manca restaurant businesses, announce unaudited interim results for the six months ended 25 September 2022. Revenues increased 26% to £49.9m (2021: £39.5m). Headline EBITDA of £10.5m (2021: £10.6m).
Orcadian Energy (ORCA), the North Sea oil and gas development company, announce its audited results for the twelve months ended 30 June 2022. The company said the last year has seen a seismic shift in sentiment surrounding the oil and gas sector. It believes the Pilot project has the potential to significantly contribute to this for the UK, whilst being a flagship project demonstrating how to reduce global emissions and make a contribution to a secure transition to net zero.
Tintra (TNT) confirmed that further to the announcement of 30 November 2022, it has received the subscription agreement under the current funding round for $10,000,000. The Subscription has been agreed with the Family Office of a Gulf-based investor. The Subscription will be made through a new special purpose vehicle.
Nostra Terra (NTOG), the international oil & gas exploration and production company, announced a significant expansion in its Senior Lending Facility, along with an increase in the company’s asset value. WAFD, the provider of the Facility, estimate of Future Net Income has increased by 6% whilst Net Present Value (at a 10% discount rate) has increased by 18% since the prior redetermination in March 2022.
Beowulf (BEM), the mineral exploration and development company, provided an update regarding two licences added to the Vardar Minerals Ltd exploration portfolio, both located along the highly prospective Vardar lead-zinc-silver trend in northern Kosovo. Beowulf owns 59.5 per cent. of Vardar.
Mast Energy Developments (MAST), the UK-based multi-asset owner, announced that it has agreed a settlement with regards to the deferred consideration owing under the Sale and Purchase Agreement to the vendor, Apex Energy Ltd of its current flagship producing asset, the 9 MW Pyebridge Synchronous Gas-powered Flexible Generation Facility, further to its initial announcement related to the acquisition of the Site.
Kodal Minerals (KOD), the mineral exploration and development company, provided an update on project development progress at its Bougouni Lithium Project in southern Mali. The company is committed to accelerating the development of the Project through the lower capital cost dense media separation processing plant option, which will also allow the Company to take advantage of a near-term buoyant lithium market.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
